
IndraLab
Statements
sparser
"A recent study performed by Wei revealed higher expression of CACNA1G-AS1 in colorectal cancer (CRC) tissues compared to adjacent normal tissues and found that CACNA1G-AS1 was able to enhance proliferative and invasive abilities of CRC cells by downregulating p53 via forming a carcinogenic complex with EZH2 ( xref )."
sparser
"Two additional ncRNAs were also shown to affect p53 levels: the lncRNA CACNA1G-AS1, which decreases p53 levels, is more highly expressed in CRC tissues than in adjacent normal tissue, whereas the circular RNA, circZNF609, which enhances p53 levels, shows decreased expression in CRC compared with adjacent normal tissue [ xref , xref ]."
sparser
"Furthermore, a lncRNA-based risk score was developed by integrating the expression data for these 11 lncRNAs with corresponding coefficients weighted by the LASSO model as follows: Risk score = (0.147 × LINC02408 expression value) + (-0.066 × LINC00488 expression value) + (-0.161 × LINC00337 expression value) + (0.104 × Z98257.1 expression value) + (-0.129 × CHRM3-AS2 expression value) + (-0.14 × C4A-AS1 expression value) + (-0.156 × AC104667.2 expression value) + (0.088 × AC087521.1 expression value) + (-0.159 × SOCS2-AS1 expression value) + (0.096 × AC010275.1 expression value) + (0.111 × CACNA1G-AS1 expression value)."
sparser
"Finally, we performed multivariate Cox regression analysis for five optimal lncRNA biomarkers and constructed a lncRNA-based risk score model based on the linear combination of the expression of five optimal lncRNA biomarkers, weighted by their coefficients from the multivariate regression analysis as follows: EpiLncRNASig = (0.197) ∗ expression ( LINC00189 ) + (0.167) ∗ expression ( CACNA1G-AS1 ) + (−0.432) ∗ expression ( AL133467.1 ) + (−0.374) ∗ expression ( CHRM3-AS2 ) + (0.395) ∗ expression ( AC105384.1 )."
sparser
"By analyzing CACNA1G-AS1 expression levels in 122 pairs of non-small cell lung cancer (NSCLC) and normal tissue samples as well as in NSCLC cell lines, xref identified CACNA1G-AS1 as an oncogene to promote cell migration, invasion, and epithelial-mesenchymal transition via regulating HNRNPA2B1 ."
sparser
"CACNA1G‐AS1 promoted the progression of HCC via competitively binding miR‐2392 and alleviating its inhibition on C1orf61. xref MCM3AP‐AS1 promoted the expression of FOXA1 through targeting miR‐194‐5p and thus exerted an oncogenic role in HCC. xref DSCR8 facilitated the activation of the Wnt/β‐catenin signaling pathway in HCC via the DSCR8/miR‐485‐5p/FZD7 axis. xref A few studies identified HCC‐related potential prognostic biomarkers via the construction of the ceRNA network. xref , xref , xref However, they were based on online tools that failed to take complex interactions among genes or disease‐specific data features into account."
sparser
"As shown in xref , three lncRNAs ( LINC00189 , CACNA1G-AS1 , and AC105384.1 ) revealed significantly higher expression in the high-risk group compared to those in the low-risk group, and two lncRNAs ( AL133467.1 and CHRM3-AS2 ) are significantly upregulated in the low-risk group and down-regulated in the high-risk group ( xref )."
sparser
"Microarray profiling of long noncoding RNAs (lncRNAs) has also been performed in lesional keloid tissue, identifying altered expression of CACNA1G-AS1 and HNF1A-AS1, which interact not only with pro-fibrotic TGF-β pathways, but also with cellular adhesion and tight junction signaling [ xref , xref ]."